Abpro Bio Co., Ltd. (KOSDAQ:195990)
South Korea · Delayed Price · Currency is KRW 1,400.00
0.00 (0.00%)
At close: Feb 19, 2026
Abpro Bio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -70,029 | -15,629 | -25,742 | -8,145 | -10,030 | -58,972 |
Depreciation & Amortization | 1,656 | 1,484 | 1,870 | 1,402 | 2,625 | 7,248 |
Loss (Gain) From Sale of Assets | 21.87 | -11,797 | 79.93 | -142.24 | -1,013 | -218.45 |
Asset Writedown & Restructuring Costs | 2,192 | 2,191 | 254.14 | - | 748.73 | 11,489 |
Loss (Gain) From Sale of Investments | 2.77 | -7.36 | 3,238 | -2,218 | 3,950 | 974.88 |
Loss (Gain) on Equity Investments | 63,737 | 27,881 | 9,377 | -4,219 | 5,876 | 13,194 |
Stock-Based Compensation | 220.97 | - | - | - | 260.5 | 334.8 |
Provision & Write-off of Bad Debts | -3,897 | -3,782 | 195.08 | -17.77 | -1,209 | 1,396 |
Other Operating Activities | -4,219 | -9,327 | 3,750 | 6,387 | -3,969 | 20,727 |
Change in Accounts Receivable | 5,367 | 1,676 | 133.03 | -488.08 | 2,519 | -1,328 |
Change in Inventory | 3,615 | 4,461 | 4,677 | -3,553 | 1,461 | 10,901 |
Change in Accounts Payable | -5,790 | -1,190 | -996.65 | -1,347 | 567.74 | 659.82 |
Change in Unearned Revenue | - | - | - | - | - | -2,299 |
Change in Income Taxes | - | - | - | - | 0.01 | - |
Change in Other Net Operating Assets | -2,566 | -1,713 | -1,698 | -119.35 | -4,005 | -1,346 |
Operating Cash Flow | -9,689 | -5,752 | -4,862 | -12,461 | -2,220 | 2,761 |
Operating Cash Flow Growth | - | - | - | - | - | 3.29% |
Capital Expenditures | -12,209 | -17,109 | -1,148 | -132.25 | -542.24 | -270.79 |
Sale of Property, Plant & Equipment | 29,036 | 28,932 | 60.11 | 5.18 | 53.1 | 637.36 |
Cash Acquisitions | 0 | -9,986 | -7,155 | - | - | -355.97 |
Divestitures | - | - | - | - | 1,606 | - |
Sale (Purchase) of Intangibles | -215.04 | 1,193 | -1,090 | 1,347 | -3,244 | -382.78 |
Investment in Securities | 2,665 | -8,198 | 16,416 | -14,012 | -161 | 149.89 |
Other Investing Activities | -28,253 | 2,442 | 134.18 | -7,663 | 4,846 | 19.23 |
Investing Cash Flow | -10,597 | -6,788 | 5,633 | -21,352 | 8,348 | -405.95 |
Short-Term Debt Issued | - | 5,593 | - | - | - | 2,604 |
Long-Term Debt Issued | - | 17,240 | 6,900 | - | 14,616 | 10,000 |
Total Debt Issued | 8,587 | 22,833 | 6,900 | - | 14,616 | 12,604 |
Short-Term Debt Repaid | - | -5,677 | -150 | - | -56.83 | -3,101 |
Long-Term Debt Repaid | - | -8,582 | -5,572 | -3,373 | -236.25 | -390.08 |
Total Debt Repaid | -8,593 | -14,259 | -5,722 | -3,373 | -293.08 | -3,491 |
Net Debt Issued (Repaid) | -5.7 | 8,573 | 1,178 | -3,373 | 14,323 | 9,113 |
Issuance of Common Stock | - | - | - | - | 5,980 | - |
Other Financing Activities | -0 | -0 | -0 | - | - | 220.68 |
Financing Cash Flow | -5.7 | 8,573 | 1,178 | -3,373 | 20,303 | 9,334 |
Foreign Exchange Rate Adjustments | 309.67 | 604.41 | -44.09 | 177.25 | 688.93 | 476.48 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | -281.82 |
Net Cash Flow | -19,982 | -3,362 | 1,905 | -37,009 | 27,120 | 11,883 |
Free Cash Flow | -21,898 | -22,861 | -6,011 | -12,593 | -2,762 | 2,490 |
Free Cash Flow Margin | -60.52% | -72.20% | -23.69% | -56.95% | -8.39% | 6.96% |
Free Cash Flow Per Share | -769.08 | -784.09 | -216.00 | -469.40 | -102.45 | 116.20 |
Cash Interest Paid | 1,059 | 628.37 | 417.18 | 397.92 | 400.65 | 742.19 |
Cash Income Tax Paid | 55.59 | -0.05 | 138.89 | -34.96 | 130.45 | 24.94 |
Levered Free Cash Flow | -12,041 | -19,266 | -6,703 | -6,719 | -12,719 | 17,127 |
Unlevered Free Cash Flow | -11,052 | -17,960 | -5,240 | -3,849 | -8,432 | 20,219 |
Change in Working Capital | 625.76 | 3,235 | 2,115 | -5,508 | 542.37 | 6,588 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.